Humedix Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
23,544
29,182
42,133
47,134
54,727
Cost of Goods Sold (COGS) incl. D&A
11,795
15,038
20,560
24,873
30,857
Gross Income
11,748
14,143
21,573
22,261
23,870
SG&A Expense
4,208
6,099
7,487
9,351
11,935
EBIT
7,526
8,015
14,050
12,839
11,859
Unusual Expense
1,662
-
135
1,575
-
Non Operating Income/Expense
46
35
28
309
3,637
Interest Expense
608
269
23
1
140
Pretax Income
8,725
8,008
14,981
12,474
15,882
Income Tax
412
1,366
3,358
2,004
2,505
Consolidated Net Income
9,137
6,642
11,623
10,470
13,376
Net Income
9,137
6,642
11,623
10,275
11,548
Net Income After Extraordinaries
9,137
6,642
11,623
10,275
11,548
Net Income Available to Common
9,137
6,642
11,623
10,275
11,548
EPS (Basic)
1,120.15
1,093.96
1,315.59
1,133.33
1,336.00
Basic Shares Outstanding
8
6
9
9
9
EPS (Diluted)
1,178.88
1,058.92
1,305.98
1,133.51
1,335.58
Diluted Shares Outstanding
8
6
9
9
9
EBITDA
8,716
9,254
15,552
15,075
16,568
Other Operating Expense
15
29
37
71
76
Non-Operating Interest Income
100
227
1,061
902
526
Minority Interest Expense
-
-
-
195
1,828

About Humedix Co.

View Profile
Address
Unit 603, Anyang Mega Valley
Anyang GY 14056
Korea, Republic Of
Employees -
Website http://www.humedix.com
Updated 09/14/2018
Humedix Co., Ltd. is a holding company, which engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. It offers dermal filler, specialty medicines, ophthalmic solvent, medicine raw materials, and cosmetics. The company was founded on February 27, 2003 and is headquartered in Anyang, South Korea.